相关实验视频
Updated: May 13, 2026
08:43
A Unified Methodological Framework for Vestibular Schwannoma Research
Published on: June 20, 2017
7.4K
胸部瘤的综合性外科治疗:对98种病变进行了回顾性多中心研究
Giuseppe Corazzelli1,2, Sergio Corvino2, Maria Marvulli3
1Neurosurgery Department, Santa Maria delle Grazie Hospital, ASL Napoli 2 Nord, Naples , Italy.
Neurosurgery
|November 1, 2024
概括
胸部神经瘤 (TSs) 的最佳手术管理因Eden类型而异. 结合神经外科和视频辅助胸腔镜手术 (VATS) 是最好的类型III,而VATS单独是最好的类型IVTS.
科学领域:
- 神经外科 神经外科
- 胸部外科手术 胸部外科手术
- 在瘤学瘤学.
背景情况:
- 对胸部神经瘤 (TSs) 的最佳外科治疗进行了辩论.
- 视频辅助胸腔镜手术 (VATS) 和结合VATS与神经外科手术的手术对特定的损伤类型有希望.
- 需要进一步了解瘤复发的预后因素.
研究的目的:
- 根据伊甸园分类来确定胸部神经瘤的最佳手术方法.
- 确定手术治疗的胸部神经瘤中瘤复发的预测因素.
主要方法:
- 98名经过手术治疗的TS患者 (2011-2023) 的回顾性多中心观察研究.
- 对手术前和6个月后的临床和外科参数进行分析.
- 根据伊甸园的类型,手术方法有所不同:细叶切除术/细叶切除术 (I型),细叶切除术/胸部跨脚切除术 (TPD) (II型),细叶切除术±VATS (III型),VATS/胸部切除术 (IV型).
主要成果:
- 对于I型的TS来说, Hemilaminectomy和Laminectomy之间没有显著的差异.
- 对于II型的TPD方法,结果与切除术类似,但手术时间较长.
- 结合神经外科和VATS的方法优于单独的神经外科治疗的第三类.
- 对于IV型患者来说,VATS比开放胸切除术 (OT) 更有利.
- 多变量分析确定了性别,瘤位置,切除程度和病理学作为复发预测因素.
结论:
- 结合神经外科和VATS的方法在伊甸园III型胸部神经瘤中产生更好的结果.
- 在伊甸园IV型胸部瘤中,VATS优于开放胸切除术.
- 对于伊甸园类型I和II,基于细叶切除术的具体方法显示了可比的结果.
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...